BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1270091)

  • 1. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of subjects as slow or rapid inactivators of isoniazid oral administration of a slow-release preparation of isoniazid and determination of the ratio of acetylisoniazid to isoniazid in urine.
    Kailasam S; Immanuel C; Nair NG; Radhakrishma S; Tripathy SP
    Indian J Med Res; 1975 Feb; 63(2):323-8. PubMed ID: 1213728
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of isoniazid and acetylisoniazid in the urine for phenotyping isoniazid inactivators].
    Yan DX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Apr; 6(2):71-3. PubMed ID: 6628126
    [No Abstract]   [Full Text] [Related]  

  • 6. Simple method for determining isoniazid acetylator phenotype.
    Russell DW
    Br Med J; 1970 Aug; 3(5718):324-5. PubMed ID: 5451955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
    Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ion-pair high-performance liquid chromatographic determination of isoniazid and acetylisoniazid in plasma and urine. Application for acetylator phenotyping.
    Svensson JO; Muchtar A; Ericsson O
    J Chromatogr; 1985 May; 341(1):193-7. PubMed ID: 4019685
    [No Abstract]   [Full Text] [Related]  

  • 9. [Testing for heterogeneity in genetic polymorphism of N-acetylation using isoniazid by metameters--probit, logit, and arcsine transformation].
    Kohno H; Mori M; Katayama T
    Kekkaku; 1993 Aug; 68(8):511-6. PubMed ID: 8377325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoniazid acetylation in São Paulo descendants of Japanese].
    Garlipp CR; Ramalho AS; Beiguelman B
    AMB Rev Assoc Med Bras; 1982; 28(7-8):179-81. PubMed ID: 6984947
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
    Loos U; Musch E; Schwabe HK
    Pneumologie; 1990 Feb; 44 Suppl 1():488-9. PubMed ID: 2367445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rifampin, phenobarbital pretreatment, and acetylator phenotype on acetylisoniazid metabolism in the rabbit.
    Thomas BH; Zeitz W; Whitehouse LW
    Can J Physiol Pharmacol; 1987 Mar; 65(3):419-23. PubMed ID: 3580961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
    Bouayad Z; Chevalier B; Maurin R; Bartal M
    Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of a method of analysis using high performance liquid chromatography of isoniazid and acetylisoniazid to determine the phenotype of acetylation].
    Miscoria G; Leneveu A; Walle C; Roux A
    Ann Biol Clin (Paris); 1988; 46(9):734-40. PubMed ID: 3223632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isoniazid acetylation in Gilbert's syndrome].
    Pereira-Filho RA; Sevá-Pereira A; de Magalhães AF
    Arq Gastroenterol; 1985; 22(4):172-5. PubMed ID: 3837656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple method for determining acetylator phenotype using isoniazid.
    Hutchings A; Routledge PA
    Br J Clin Pharmacol; 1986 Sep; 22(3):343-5. PubMed ID: 3768246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population screening for isoniazid acetylator phenotype.
    Seifart HI; Parkin DP; Botha FJ; Donald PR; Van Der Walt BJ
    Pharmacoepidemiol Drug Saf; 2001; 10(2):127-34. PubMed ID: 11499851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.